CD8+ t cell-mediated regulation of synaptic integrity in Alzheimer’s disease
- 1The Second Clinical Medical College, Heilongjiang University of Chinese Medicine , , ,
- 2The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine , , ,
Abstract
Alzheimer’s disease (AD) has traditionally been interpreted through amyloid, tau, and innate immune frameworks, with the complement cascade long regarded as the principal driver of aberrant synaptic pruning. Synaptic loss is increasingly recognized as one of the strongest correlates of cognitive decline. This review examines an emerging CD8 ⁺ T cell–synapse axis that extends beyond complement-centric models. We discuss how brain-infiltrating CD8 ⁺ T cells intersect with synaptic integrity through MHC-I-dependent and MHC-I-independent mechanisms, including IFN-γ–mediated microglial reprogramming and granzyme K–driven non-canonical complement activation. Early effector-like subsets may promote neuroinflammation and synaptic injury, whereas later tissue-resident or regulatory populations can exert protective functions by gating microglial states. The net outcome depends on disease stage, antigenic milieu, anatomical niche, and microglial context. We emphasize that direct antigen-specific, MHC-I-restricted synaptic attack remains unproven in human AD, and that observed T-cell infiltration may reflect reverse causality. Translational limitations across species are evaluated, and we outline subset-specific immunomodulation, ApoE4-stratified strategies, and biomarker-guided trial designs as future directions. Overall, CD8 ⁺ T cells are positioned not as uniform cytotoxic executors, but as dynamic, context-dependent regulators of synaptic outcomes in AD.
Related
- Selenium-engineered self-assembling protein nanoparticles rescue synaptic integrity and cognition via ferroptosis inhibition in Alzheimer’s mice
- Disrupted synaptic vacuolar H+-ATPase renders synaptic vulnerability to Alzheimer’s disease
- Plasma β‐synuclein associates with hippocampal synaptic density measured with [11C]UCB‐J PET and plasma tau markers in Alzheimer's disease
- PLCG2 downregulation impairs synaptic function and increases Alzheimer’s disease hallmarks in neuronal cultures
- The Association of Amyloid-β and Tau With Synaptic Dysfunction in Alzheimer's Disease.
BibTeX
@article{fu2026cellmediated,
title = {{CD8+ t cell-mediated regulation of synaptic integrity in Alzheimer’s disease}},
author = {Hua Fu and Jing Yang and Miao Zhang},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1903001},
url = {https://europepmc.org/article/PMC/PMC13669829},
note = {CC BY},
}
RIS
TY - JOUR
TI - CD8+ t cell-mediated regulation of synaptic integrity in Alzheimer’s disease
AU - Hua Fu
AU - Jing Yang
AU - Miao Zhang
PY - 2026
DA - 2026/10/01
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1903001
UR - https://europepmc.org/article/PMC/PMC13669829
AB - Alzheimer’s disease (AD) has traditionally been interpreted through amyloid, tau, and innate immune frameworks, with the complement cascade long regarded as the principal driver of aberrant synaptic pruning. Synaptic loss is increasingly recognized as one of the strongest correlates of cognitive decline. This review examines an emerging CD8 ⁺ T cell–synapse axis that extends beyond complement-centric models. We discuss how brain-infiltrating CD8 ⁺ T cells intersect with synaptic integrity through MHC-I-dependent and MHC-I-independent mechanisms, including IFN-γ–mediated microglial reprogramming and granzyme K–driven non-canonical complement activation. Early effector-like subsets may promote neuroinflammation and synaptic injury, whereas later tissue-resident or regulatory populations can exert protective functions by gating microglial states. The net outcome depends on disease stage, antigenic milieu, anatomical niche, and microglial context. We emphasize that direct antigen-specific, MHC-I-restricted synaptic attack remains unproven in human AD, and that observed T-cell infiltration may reflect reverse causality. Translational limitations across species are evaluated, and we outline subset-specific immunomodulation, ApoE4-stratified strategies, and biomarker-guided trial designs as future directions. Overall, CD8 ⁺ T cells are positioned not as uniform cytotoxic executors, but as dynamic, context-dependent regulators of synaptic outcomes in AD.
SN - 1664-3224
ER -